{
  "id": 181281,
  "name": "HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.)",
  "slug": "healthcare-distribution-alliance-healthcare-distribution-managment-assn",
  "state": "VA",
  "description": null,
  "totalSpending": 2880000,
  "filings": 36,
  "yearlySpending": [
    {
      "year": 2018,
      "income": 320000
    },
    {
      "year": 2019,
      "income": 320000
    },
    {
      "year": 2020,
      "income": 400000
    },
    {
      "year": 2021,
      "income": 320000
    },
    {
      "year": 2022,
      "income": 480000
    },
    {
      "year": 2023,
      "income": 320000
    },
    {
      "year": 2024,
      "income": 320000
    },
    {
      "year": 2025,
      "income": 400000
    }
  ],
  "firms": [
    "TARPLIN, DOWNS & YOUNG, LLC"
  ],
  "lobbyists": [
    "RAISSA DOWNS",
    "JENNIFER YOUNG",
    "MICHELLE EASTON",
    "ELIZABETH MURRAY",
    "CHARLOTTE IVANCIC",
    "PAMELA SMITH",
    "EMILY MURRY",
    "KIMBERLY BRANDT",
    "MARGARET JOSEPH",
    "PETER FISE",
    "LAURA FRIEDEL",
    "PARICK CARROLL"
  ],
  "issues": [
    "PHA",
    "TAX",
    "HCR",
    "BUD",
    "MMM",
    null
  ],
  "sampleDescriptions": [
    "Importation of prescription drugs (S. 469, S. 771, H.R. 1776, H.R. 1245, H.R. 934, H.R. 1480, S. 92, S. 64)\n\nOpioid Drug Abuse - General issues related to opioid drug abuse\nEnsuring Patient Access and Effective Enforcement Act (PL 114-145)\nImplementation of Public Law 113-54 (DSCSA)",
    "LIFO Accounting Methodology (H.R. 1)",
    "Pandemic All - Hazards Preparedness Act",
    "H.R. 1625 - Consolidated Appropriations Act of 2018\nH.R. 1892 - Bipartisan Budget Act of 2018",
    "Average Sales Price (H.R. 1920, S. 1304)\nPPACA Implementation (PL 111-148)\nCenters for Medicare and Medicaid Services (AMP and NADAC)",
    "Pandemic All - Hazards Preparedness Act (S. 2852, House draft bill)",
    "Average Sales Price (H.R. 1920, S. 1304)",
    "Importation of prescription drugs (S. 469, S. 771, H.R. 1776, H.R. 1245, H.R. 934, H.R. 1480, S. 92, S. 64)\n\nOpioid Abuse - General issues related to opioid drug abuse (H.R. 6, S. 2838, S. 2837)\nEnsuring Patient Access and Effective Enforcement Act (PL 114-145)\nImplementation of Public Law 113-54 (DSCSA)",
    "Importation of prescription drugs (S. 469, S. 771, H.R. 1776, H.R. 1245, H.R. 934, H.R. 1480, S. 92, S. 64)\nOpioid Abuse - General issues related to opioid drug abuse (H.R. 6, H.R. 6779, H.R. 6600, S. 2838, S. 2837, S. 3120, S. 2680, S.3282)\nEnsuring Patient Access and Effective Enforcement Act (PL 114-145)\nImplementation of Public Law 113-54 (DSCSA)",
    "Pandemic All - Hazards Preparedness Act (S. 2852, H.R. 6378)",
    "Pandemic All - Hazards Preparedness Act (S. 2852, H.R. 6378)\nIssues related to the RFI on the HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs\nH.R. 695 - Department of Defense Appropriations Act",
    "Importation of prescription drugs (H.R. 447, H.R. 478, H.R. 1478, S. 61, S. 97, S. 658, S. 844)\nOpioid Abuse - General issues related to opioid drug abuse (Implementation of Public Law 115-271)\nImplementation of Public Law 113-54 (DSCSA)\nIssues Related to ARCOS DATA",
    "Pandemic All - Hazards Preparedness Act (H.R. 269)\nGeneral issues related to drug cost oversight",
    "Pandemic All - Hazards Preparedness Act (H.R. 269, S. 1379)\nGeneral issues related to drug cost oversight\nS. 1895 - Lower Health Care Costs Act",
    "Importation of prescription drugs (H.R. 447, H.R. 478, H.R. 1478, S. 61, S. 97, S. 658, S. 844)\nOpioid Abuse - General issues related to opioid drug abuse (Implementation of Public Law 115-271)\nImplementation of Public Law 113-54 (DSCSA)\nIssues Related to ARCOS data and suspicious order record requirements & reporting",
    "General issues related to drug cost oversight\nS. 1895 - Lower Health Care Costs Act\nH.R. 3 - Lower Drug Costs Now Act\nS. 2543 - Prescription Drug Pricing Reduction Act",
    "H.R. 3164 - Agriculture, Rural Development, FDA, and Related Agencies Appropriations\nH.R. 4378 - Continuing Appropriations Act and Health Extenders Act",
    "H.R. 3164 - Agriculture, Rural Development, FDA, and Related Agencies Appropriations\nH.R. 4378 - Continuing Appropriations Act and Health Extenders Act\nH.R. 1865 - Further Consolidated Appropriations Act, 2020\nH.R. 3055 - Further Continuing Appropriations Act, 2020, and Further Health Extenders Act",
    "Importation of prescription drugs (H.R. 447, H.R. 478, H.R. 1478, S. 61, S. 97, S. 658, S. 844)\nOpioid Abuse - General issues related to opioid drug abuse (Implementation of Public Law 115-271)\nImplementation of Public Law 113-54 (DSCSA)\nIssues Related to ARCOS data and suspicious order record requirements & reporting\nBlock, Report, and Suspend Suspicious Shipments Act of 2019 (H.R. 3878)",
    "General issues related to drug cost oversight\nS. 1895 - Lower Health Care Costs Act\nH.R. 3 - Lower Drug Costs Now Act\nS. 2543 - Prescription Drug Pricing Reduction Act\nH.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020\nH.R. 6201 - Families First Coronavirus Response Act\nS. 3548 - CARES Act"
  ],
  "years": [
    2018,
    2019,
    2020,
    2021,
    2022,
    2023,
    2024,
    2025
  ],
  "growthRate": 25,
  "trajectory": "stable",
  "yearsActive": 8,
  "avgAnnualSpending": 360000,
  "peakYear": 2022,
  "lobbyistCount": 12,
  "firmCount": 1,
  "issueCount": 5,
  "industry": "healthcare"
}